Back
American Vanguard 10K Form
Buy
54
AVD
American Vanguard
Last Price:
5.91
Seasonality Move:
7.92%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | AVD/American Vanguard Quarterly |
2023-11-09 | 10Q | AVD/American Vanguard Quarterly |
2023-08-09 | 10Q | AVD/American Vanguard Quarterly |
2023-05-10 | 10Q | AVD/American Vanguard Quarterly |
2022-11-08 | 10Q | AVD/American Vanguard Quarterly |
2022-08-08 | 10Q | AVD/American Vanguard Quarterly |
Receive AVD News And Ratings
See the #1 stock for the next 7 days that we like better than AVD
AVD Financial Statistics
Sales & Book Value
Annual Sales: | $579.37M |
---|---|
Cash Flow: | $-16.91M |
Price / Cash Flow: | 0 |
Annual Sales: | $12.29 |
Price / Book: | 0.46 |
Profitability
EPS (TTM): | -0.13000 |
---|---|
Net Income (TTM): | $-3.52M |
Gross Margin: | $179.16M |
Return on Equity: | -0.96% |
Return on Assets: | -0.45% |
American Vanguard Earnings Forecast
Key American Vanguard Financial Ratios
- The Gross Profit Margin over the past 38 years for AVD is 30.92%.
- The Selling, General & Administrative Expenses for AVD have been equal to 18.05% of Gross Profit Margin.
- The Research & Development expenses have been 6.56% of Revenue.
- The Interest Expense is 169.60% of Operating Income.
- The Net Earning history of AVD is 1.30% of Total Revenues.
- Per Share Earnings over the last 38 years have been positive in 25 years.
American Vanguard Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Chemicals |
Sector: | Materials |
Current Symbol: | AVD |
CUSIP: | 030371 |
Website: | american-vanguard.com |
Debt
Debt-to-Equity Ratio: | 0.6 |
---|---|
Current Ratio: | 2.22 |
Quick Ratio: | 1.04 |
Price-to-Earnings
Trailing P/E Ratio: | 21.77 |
---|---|
Forward P/E Ratio: | 0 |
AVD Technical Analysis vs Fundamental Analysis
Buy
54
American Vanguard (AVD)
is a Buy
Is American Vanguard a Buy or a Sell?
-
American Vanguard stock is rated a Buy
The current American Vanguard [AVD] share price is $5.66. The Score for AVD is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.